RETRACTED: In Vitro Neuroprotective Effect Evaluation of Donepezil‐Loaded PLGA Nanoparticles‐Embedded PVA/PEG Nanofibers on SH‐SY5Y Cells and AP‐APP Plasmid Related Alzheimer Cell Line Model

Abstract Recently developed nanoparticles and nanofibers present new brain‐specific treatment strategies, especially for Alzheimer's disease treatment. In this study, donepezil (DO)‐loaded PLGA nanoparticles (DNP) are embedded in PVA/PEG nanofibers (DNPF) produced by pressurized gyration for su...

Full description

Bibliographic Details
Published in:	Macromolecular Materials and Engineering
Main Authors:	Ece Guler, Humeyra Betul Yekeler, Burcu Uner, Murat Dogan, Asima Asghar, Fakhera Ikram, Yusufhan Yazir, Oguzhan Gunduz, Deepak M Kalaskar, Muhammet Emin Cam
Format:	Article
Language:	English
Published:	Wiley-VCH 2025-03-01
Subjects:	Alzheimer's disease Alzheimer's disease cell model AP‐APP plasmid transfection donepezil drug delivery nanofiber
Online Access:	https://doi.org/10.1002/mame.202400160

Similar Items

Clinical Assessment of Alzheimer’s Disease and Response to Donepezil Treatment
by: Serge Gauthier
Published: (2020-12-01)

Delirium Associated with Donepezil in a Patient with Alzheimer’s Disease: a Case Report
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01)

Effects of Donepezil Hydrochloride on Neuronal Response of Pyramidal Neuron of the CA1 Hippocampus in Rat Model of Alzheimer\'s Disease
by: Azade Eskandary, et al.
Published: (2019-03-01)

Comparative Study of Donepezil-Loaded Formulations for the Treatment of Alzheimer’s Disease by Nasal Administration
by: Lupe Carolina Espinoza, et al.
Published: (2022-11-01)

Donepezil-Induced Complex Multimodal Hallucinations: Two Cases and a Review of the Literature
by: Federico Emanuele Pozzi, et al.
Published: (2022-09-01)

Development of donepezil hydrochloride-loaded PLGA-based nanoparticles for Alzheimer’s disease treatment
by: Merve Kömür, et al.
Published: (2025-04-01)

Obsessive–compulsive disorder induced by donepezil in a patient with Alzheimer's disease
by: Kohei Echizen, et al.
Published: (2024-06-01)

Pharmacokinetic Evaluation of a Novel Donepezil-Loaded Dissolving Microneedle Patch in Rats
by: Naveed Ur Rehman, et al.
Published: (2021-12-01)

A Network Pharmacology Based Research on the Mechanism of Donepezil in Treating Alzheimer's Disease
by: Lihua Liu, et al.
Published: (2022-04-01)

Association of CHAT Gene Polymorphism rs3793790 and rs2177370 with Donepezil Response and the Risk of Alzheimer’s Disease Continuum
by: Sun H, et al.
Published: (2024-06-01)

Synthesis of New Indole Derivatives Structurally Related to Donepezil and Their Biological Evaluation as Acetylcholinesterase Inhibitors
by: Samar I. Faggal, et al.
Published: (2012-04-01)

A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa® Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer’s Disease Already Receiving Donepezil (ROMEO-AD)
by: Hee-Jin Kim, et al.
Published: (2023-05-01)

Gold Nanoparticles Loaded with Chitosan Encapsulate Donepezil as a Novel Nanocomposite for Alzheimer's Disease Therapy
by: Lina Mohammad Saleh Al-Sarayra, et al.
Published: (2024-04-01)

The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer’s disease patients: study protocol for a randomized controlled trial
by: Weina Peng, et al.
Published: (2017-07-01)

Population Pharmacokinetic Modeling and Simulation for Dose Optimization of GB-5001, a Long-Acting Intramuscular Injection of Donepezil, in Healthy Participants
by: Juyoung Khwarg, et al.
Published: (2024-08-01)

A Mathematical Study of Effects of Alzheimer’s Drug Donepezil Hydrochloride on Neuronal Viscoelasticity and Action Potentials
by: Corina S. Drapaca
Published: (2024-12-01)

Recent Advances in Donepezil Delivery Systems via the Nose-to-Brain Pathway
by: Jiyoon Jon, et al.
Published: (2025-07-01)

Effect of Donepezil and Hyoscyamoside on Improving Spatial Memory in Rats With Alzheimer\'s Disease
by: Fatemeh Heidari Soureshjani, et al.
Published: (2020-09-01)

Antagonism of morphine-induced central respiratory depression by donepezil in the anesthetized rabbit
by: MIKI TSUJITA, et al.
Published: (2007-01-01)

Development of a novel sensor for the detection of donepezil hydrochloride as Alzheimer's disease drug utilizing CuO-TiO2 hybrid nanostructures
by: Ye Zhu, et al.
Published: (2024-05-01)

Donepezil suppresses intracellular Ca2+ mobilization through the PI3K pathway in rodent microglia
by: Yoshinori Haraguchi, et al.
Published: (2017-12-01)

Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil
by: Lupe Carolina Espinoza, et al.
Published: (2019-02-01)

Brain-Targeted Polysorbate 80-Emulsified Donepezil Drug-Loaded Nanoparticles for Neuroprotection
by: Xiaojun Tao, et al.
Published: (2021-08-01)

Gintonin facilitates brain delivery of donepezil, a therapeutic drug for Alzheimer disease, through lysophosphatidic acid 1/3 and vascular endothelial growth factor receptors
by: Sun-Hye Choi, et al.
Published: (2021-03-01)

Mathematical Modeling of Alzheimer’s Drug Donepezil Hydrochloride Transport to the Brain after Oral Administration
by: Corina S. Drapaca
Published: (2024-08-01)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
by: Yoshiyuki Kagawa, et al.
Published: (2021-12-01)

Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer’s disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial
by: Yun Jeong Hong, et al.
Published: (2019-05-01)

Recent developments in the design and synthesis of benzylpyridinium salts: Mimicking donepezil hydrochloride in the treatment of Alzheimer’s disease
by: Saghi Sepehri, et al.
Published: (2022-09-01)

Effects of Donepezil Treatment on Brain Metabolites, Gut Microbiota, and Gut Metabolites in an Amyloid Beta-Induced Cognitive Impairment Mouse Pilot Model
by: Jae-Kwon Jo, et al.
Published: (2022-10-01)

Higher levels of thyroxine may predict a favorable response to donepezil treatment in patients with Alzheimer disease: a prospective, case–control study
by: Yu San Chang, et al.
Published: (2018-06-01)

Efficacy of Ginkgo biloba as an adjunct to donepezil in amyloid PET-positive Alzheimer’s patients
by: YoungSoon Yang, et al.
Published: (2025-03-01)

A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease
by: Deardorff WJ, et al.
Published: (2016-10-01)

A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study
by: Basil H. Ridha, et al.
Published: (2018-05-01)

Differential response to donepezil in MRI subtypes of mild cognitive impairment
by: Patricia Diaz-Galvan, et al.
Published: (2023-06-01)

The Effects of Donepezil on 15-Item Geriatric Depression Scale Structure in Patients with Alzheimer Disease
by: Youngsoon Yang, et al.
Published: (2016-09-01)

Efficacy of 5 and 10 mg donepezil in improving cognitive function in patients with dementia: a systematic review and meta-analysis
by: Mehak Sheikh, et al.
Published: (2024-07-01)

Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease
by: Alessia Carocci, et al.
Published: (2022-08-01)

Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model
by: Shehata MK, et al.
Published: (2023-07-01)

Investigation on formulation parameters of donepezil HCl loaded solid lipid nanoparticles
by: Gizem Rüya Topal, et al.
Published: (2023-08-01)

First Synthesis of Racemic <i>Trans</i> Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease
by: Benjamin Guieu, et al.
Published: (2020-12-01)